Patrimony

The Louis Bachelier Group's patrimony has been defined as all the publications produced by academic researchers thanks to Group funding (ILB, FdR, IEF, Labex) or via the use of EquipEx data (BEDOFIH, EUROFIDAI).


Reset

Drug launch timing and international reference pricing.

Drug launch timing, International reference pricing

Drug approval decision times, international reference pricing and strategic launches of new drugs.

Drug launch timing, International reference pricing, Marketing authorization, Sequential launching

Drug launch timing and international reference pricing.

Drug launch timing, International reference pricing

Drug approval decision times, international reference pricing and access to new drugs.

Drug launch timing, International reference pricing, Marketing authorization, Sequential launching

Drug approval decision times, international reference pricing and strategic launches of new drugs.

Drug launch timing, International reference pricing, Marketing authorization, Sequential launching

Drug approval decision times, international reference pricing and strategic launches of new drugs.

Drug launch timing, International reference pricing, Marketing authorization, Sequential launching

Comparing approval procedures for new drugs.

Access to new drugs, Drug approval, International reference pricing

Drug Launch Timing and International Reference Pricing.

drug launch timing, international reference pricing

Drug launch timing and international reference pricing.

Drug launch timing, International reference pricing

Drug approval decision times, international reference pricing and strategic launches of new drugs.

Drug launch timing, International reference pricing, Marketing authorization, Sequential launching

Drug approval decision times, international reference pricing and strategic launches of new drugs.

Drug launch timing, International reference pricing, Marketing authorization, Sequential launching

Drug launch timing and international reference pricing.

Drug launch timing, International reference pricing